Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	389.32	296.15	351.41	442.74	410.6	413.75
Revenue Growth	26.19%	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Gross Profit Gross Profit Growth	389.32	296.15	351.41	442.74	410.6	413.75
Operating Income Operating Income Growth	234.17	98.5	93.12	-945.43	250.34	232.26
Net Income Net Income Growth	129.87	24.02	0.88	-2,034	350.13	1,057
Earnings Per Share EPS Growth	0.77	0.15	0.01	-6.45	0.96	3.21
EPS Growth	-	1400.00%	-	-	-70.09%	386.36%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States United States Growth	289.34	341.22	432.99	402.79	404.65
Rest of World Rest of World Growth	6.81	10.19	9.74	7.8	9.1
Total Total Growth	296.15	351.41	442.74	410.6	413.75

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	79.13	215.46	88.56	92.15	656.2	620.13
Total Debt Total Debt Growth	396.87	597.8	599.48	715.54	415.92	475.8
Net Cash (Debt) Net Cash Growth	-317.74	-382.35	-510.92	-623.38	240.29	144.33
Net Cash Growth	-	-	-	-	66.49%	-
Net Cash Per Share Net Cash Per Share Growth	-1.89	-2.35	-3.19	-4.01	1.29	0.88

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	185.56	127.04	103.55	183.43	273.76	261.9
Capital Expenditures CapEx Growth	-0	-0.03	-0.14	-0.27	-0.14	-0.27
Free Cash Flow Free Cash Flow Growth	185.55	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Growth	519.84%	22.82%	-43.54%	-33.06%	4.58%	56.67%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	60.15%	33.26%	26.50%	-213.54%	60.97%	56.13%
Pretax Margin	53.27%	23.65%	18.55%	-214.14%	61.48%	48.50%
Profit Margin	73.18%	39.18%	36.86%	-195.28%	80.32%	-30.73%
FCF Margin	47.66%	42.89%	29.43%	41.37%	66.64%	63.23%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	5.32	22.47	443.00	-	12.91	3.63
Forward PE	3.34	7.84	13.42	14.14	11.24	8.43
P/FCF Ratio	3.73	4.33	6.86	9.77	6.97	7.22
PS Ratio	1.78	1.86	2.02	4.04	4.65	4.57

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error